243 - Rapid Fire Poster Session: COVID-19 Vaccines

Rapid Fire Moderator(s)

• 

  Kathryn Edwards, MD

  Professor of Pediatrics
  Vanderbilt University Medical Center
  Nashville, TN, United States

  Disclosure(s): Bionet: Advisor/Consultant (Ongoing); Glaxo Smith Kline: Data Monitoring Committee (Ongoing); Merck & Co. Inc: Data Monitoring Committee (Ongoing); Moderna, Inc.: Data Monitoring Committee (Ongoing); Pfizer, Inc.: Data Monitoring Committee (Ongoing); Roche Inc: Data Monitoring Committee (Ongoing); Sanofi Pasteur Inc.: Data Monitoring Committee (Ongoing); Seqirus Vaccine Ltd.: Data Monitoring Committee (Ongoing); X-4 Pharma: Adjudication Committee (Ongoing)

Presentations:

• 12:15 PM – 12:45 PM US ET

  Lower B-Cell Responses Rather Than Circulating Antibody Titres Are Associated With span SARS-CoV-2 Infection Post Third Dose COVID-19 Vaccination
  

  Rapid Fire Presenter: Joanne Byrne, MB BCh BAO – Centre for Experimental Pathogen Host Research, University College Dublin, Ireland

  Co-Author: Lili Gu, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Riya Negi, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Alejandro Garcia-Leon, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Dana Alalwan, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Colette Marie Gaillard, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Gurvin Saini, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Kelly Leamy, n/a – 3School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland 5Department of Infectious Diseases, Mater Misericordiae University Hospital, Eccles St, Dublin 7, Ireland

  Co-Author: Bearach Reynolds, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland 2Department of Infectious Diseases, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

  Co-Author: Tessa O'Gorman, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland 5Department of Infectious Diseases, Mater Misericordiae University Hospital, Eccles St, Dublin 7, Ireland

  Co-Author: Grace Kenny, MB BCh BAO MRCPI – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland 2Department of Infectious Diseases, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

  Co-Author: Cathal O'Broin, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland 2Department of Infectious Diseases, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

  Co-Author: Eoin Feeney, MD PhD – Department of St Vincent's University Hospital and Centre for Experimental Pathogen Host Research University College Dublin

  Co-Author: Obada Yousif, n/a – 4Endocrinology Department, Wexford General Hospital, Carricklawn, Wexford, Ireland

  Co-Author: Aoife Cotter, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland 5Department of Infectious Diseases, Mater Misericordiae University Hospital, Eccles St, Dublin 7, Ireland

  Co-Author: Eoghan de Barra, n/a – 6Department of Infectious Diseases, Beaumont Hospital, Beaumont, Dublin 9, Ireland 7Department of International Health and Tropical Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland

  Co-Author: Mary Horgan, n/a – 8Department of Infectious Diseases, Cork University Hospital, Wilton, Co Cork, Ireland

  Co-Author: Alan Landay, n/a – 9Department of Internal Medicine, Rush University, Chicago, Il, USA

  Co-Author: Peter Doran, n/a – 3School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Virginie Gautier, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland

  Co-Author: Patrick WG Mallon, n/a – 1Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Belfield, Dublin 4, Ireland 2Department of Infectious Diseases, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland
• 12:15 PM – 12:45 PM US ET

  The magnitude and durability of the antibody response to mRNA-based vaccination among SARS-CoV-2 seronegative and seropositive healthcare personnel
  

  Co-Author: Emily Ciccone, MD, MHS – Division of Infectious Diseases, School of Medicine, University of North Carolina

  Rapid Fire Presenter: Deanna Zhu, BA – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina

  Co-Author: Samuel Hawke, BS – Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina

  Co-Author: Rawan Ajeen, BSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina

  Co-Author: Annika Gunderson, MSc – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina

  Co-Author: Evans Lodge, BA, BS – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina

  Co-Author: Bonnie E. Shook-Sa, PhD – Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill

  Co-Author: Haley Abernathy, BS – Institute for Global Health and Infectious Diseases, University of North Carolina

  Co-Author: Haley Garrett, BS – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina

  Co-Author: Elise King, BA – Institute for Global Health and Infectious Diseases, University of North Carolina

  Co-Author: Alena Markmann, MD, PhD – Division of Infectious Diseases, School of Medicine, University of North Carolina

  Co-Author: Lakshmanane Premkumar, PhD – Institute for Global Health and Infectious Diseases, University of North Carolina

  Co-Author: Jonathan J. Juliano, MD, MSPH – University of North Carolina School of Medicine

  Co-Author: Ross M. Boyce, MD, MSc – University of North Carolina at Chapel Hill

  Co-Author: Allison Aiello, MS, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina
• 12:15 PM – 12:45 PM US ET

  Effectiveness of COVID-19 Vaccines Against Severe Disease and Death and its Durability Over Time Against the Omicron Variant
  

  Co-Author: Theodore Lytras, MD – School of Medicine, European University Cyprus, Nicosia, Cyprus.

  Co-Author: Kassiani Mellou, Epidemiologist, MPH, PhD – Hellenic National Public Health Organization

  Co-Author: Kassiani Gkolfinopoulou, RN, MPH, PhD – Hellenic National Public Health Organization

  Co-Author: Gerasimos Gerolymatos, PhD – Hellenic National Public Health Organization

  Co-Author: Dimitrios Paraskevis, Professor – Hellenic National Public Health Organization

  Co-Author: Theoklis Zaoutis, Professor – Hellenic National Public Health Organization

  Rapid Fire Presenter: Sotirios Tsiodras, MD, MSc, PhD (he/him/his) – 4th Department of Internal Medicine, University General Hospital Attikon, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece
• 12:15 PM – 12:45 PM US ET

  Immunogenicity And Safety of a Virus-Like Particle (VLP) Protein Subunit SARS-CoV-2 Vaccine in Adults: a Phase 1/2 Study
  

  Co-Author: Robert Scott, MD – University of the Sunshine Coast

  Co-Author: Susan Thackwray, MD – University of the Sunshine Coast

  Co-Author: Nicholas Hourguettes, BA – Icosavax, Inc

  Co-Author: Huub Gelderblom, MD PhD – Icosavax, Inc

  Rapid Fire Presenter: Niranjan Kanesa-thasan, MD, MTMH – Icosavax, Inc.